| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione binding | 2.70e-06 | 18 | 112 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 4.24e-06 | 20 | 112 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 2.00e-05 | 29 | 112 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 3.08e-04 | 5 | 112 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 4.60e-04 | 64 | 112 | 4 | GO:0016765 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 4.62e-07 | 29 | 112 | 5 | GO:0042759 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 6.21e-07 | 4 | 112 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.64e-06 | 37 | 112 | 5 | GO:0042178 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 8.56e-06 | 8 | 112 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 2.49e-05 | 11 | 112 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.28e-05 | 13 | 112 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.28e-05 | 13 | 112 | 3 | GO:1900116 | |
| Domain | GST_mu | 6.79e-09 | 5 | 115 | 4 | IPR003081 | |
| Domain | Ankyrin_rpt | POTEB3 LRRK2 POTED ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 6.59e-07 | 262 | 115 | 11 | IPR002110 |
| Domain | ANK | POTEB3 POTED ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 3.48e-06 | 251 | 115 | 10 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 POTED ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 3.73e-06 | 253 | 115 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 LRRK2 ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 3.87e-06 | 254 | 115 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | POTEB3 POTED ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 3.87e-06 | 254 | 115 | 10 | PS50297 |
| Domain | - | 4.49e-06 | 6 | 115 | 3 | 3.90.1290.10 | |
| Domain | Plectin_repeat | 7.82e-06 | 7 | 115 | 3 | IPR001101 | |
| Domain | Plectin | 7.82e-06 | 7 | 115 | 3 | PF00681 | |
| Domain | PLEC | 7.82e-06 | 7 | 115 | 3 | SM00250 | |
| Domain | GST_N | 9.16e-06 | 22 | 115 | 4 | PF02798 | |
| Domain | GST_NTER | 9.16e-06 | 22 | 115 | 4 | PS50404 | |
| Domain | GST_C | 1.84e-05 | 26 | 115 | 4 | IPR004046 | |
| Domain | GST_C | 1.84e-05 | 26 | 115 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 2.15e-05 | 27 | 115 | 4 | IPR004045 | |
| Domain | - | POTEB3 LRRK2 ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 ANKRD20A1 | 2.30e-05 | 248 | 115 | 9 | 1.25.40.20 |
| Domain | Spectrin_repeat | 2.88e-05 | 29 | 115 | 4 | IPR002017 | |
| Domain | TAF_II_230-bd | 3.76e-05 | 2 | 115 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 3.76e-05 | 2 | 115 | 2 | IPR022591 | |
| Domain | - | 3.76e-05 | 2 | 115 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 3.76e-05 | 2 | 115 | 2 | PF09247 | |
| Domain | DUF3591 | 3.76e-05 | 2 | 115 | 2 | PF12157 | |
| Domain | TAF1_animal | 3.76e-05 | 2 | 115 | 2 | IPR011177 | |
| Domain | Spectrin/alpha-actinin | 4.29e-05 | 32 | 115 | 4 | IPR018159 | |
| Domain | SPEC | 4.29e-05 | 32 | 115 | 4 | SM00150 | |
| Domain | GST_CTER | 5.48e-05 | 34 | 115 | 4 | PS50405 | |
| Domain | Ank_2 | POTEB3 ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 ANKRD20A1 | 5.57e-05 | 215 | 115 | 8 | PF12796 |
| Domain | Ank | POTED ANKRD20A2P ANKRD20A3P POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 8.41e-05 | 228 | 115 | 8 | PF00023 |
| Domain | Glutathione-S-Trfase_C-like | 9.50e-05 | 39 | 115 | 4 | IPR010987 | |
| Domain | - | 9.50e-05 | 39 | 115 | 4 | 1.20.1050.10 | |
| Domain | FBN | 1.12e-04 | 3 | 115 | 2 | IPR011398 | |
| Domain | Actinin_actin-bd_CS | 3.68e-04 | 23 | 115 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 3.68e-04 | 23 | 115 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.68e-04 | 23 | 115 | 3 | PS00019 | |
| Domain | cEGF | 5.33e-04 | 26 | 115 | 3 | IPR026823 | |
| Domain | cEGF | 5.33e-04 | 26 | 115 | 3 | PF12662 | |
| Domain | Integrin_bsu_cyt_dom | 5.55e-04 | 6 | 115 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 5.55e-04 | 6 | 115 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 5.55e-04 | 6 | 115 | 2 | PF08725 | |
| Domain | Integrin_bsu_tail | 7.74e-04 | 7 | 115 | 2 | IPR012896 | |
| Domain | TB | 7.74e-04 | 7 | 115 | 2 | PF00683 | |
| Domain | Integrin_B_tail | 7.74e-04 | 7 | 115 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 7.74e-04 | 7 | 115 | 2 | PF07965 | |
| Domain | Integrin_beta | 1.03e-03 | 8 | 115 | 2 | PF00362 | |
| Domain | - | 1.03e-03 | 8 | 115 | 2 | 3.90.290.10 | |
| Domain | INB | 1.03e-03 | 8 | 115 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.03e-03 | 8 | 115 | 2 | IPR002369 | |
| Domain | Integrin_bsu | 1.32e-03 | 9 | 115 | 2 | IPR015812 | |
| Domain | Integin_beta_N | 1.32e-03 | 9 | 115 | 2 | IPR033760 | |
| Domain | TB | 1.32e-03 | 9 | 115 | 2 | PS51364 | |
| Domain | TB_dom | 1.32e-03 | 9 | 115 | 2 | IPR017878 | |
| Domain | INTEGRIN_BETA | 1.32e-03 | 9 | 115 | 2 | PS00243 | |
| Domain | PSI_integrin | 1.32e-03 | 9 | 115 | 2 | PF17205 | |
| Domain | R3H | 1.32e-03 | 9 | 115 | 2 | SM00393 | |
| Domain | GST_C_3 | 1.64e-03 | 10 | 115 | 2 | PF14497 | |
| Domain | R3H | 1.99e-03 | 11 | 115 | 2 | PS51061 | |
| Domain | R3H | 1.99e-03 | 11 | 115 | 2 | PF01424 | |
| Domain | - | 1.99e-03 | 11 | 115 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 1.99e-03 | 11 | 115 | 2 | IPR001374 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 3.00e-06 | 19 | 77 | 4 | M47809 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 6.73e-06 | 23 | 77 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 8.05e-06 | 24 | 77 | 4 | M47487 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.91e-05 | 70 | 77 | 5 | M16794 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 4.24e-05 | 36 | 77 | 4 | M1443 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.48e-05 | 72 | 77 | 5 | M9257 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 5.27e-05 | 38 | 77 | 4 | MM14600 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 1.57e-04 | 50 | 77 | 4 | M1840 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 4.17e-04 | 27 | 77 | 3 | MM15908 | |
| Pubmed | 2.20e-11 | 8 | 117 | 5 | 12475935 | ||
| Pubmed | 6.07e-10 | 5 | 117 | 4 | 18551009 | ||
| Pubmed | 6.07e-10 | 5 | 117 | 4 | 19856098 | ||
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 3.71e-08 | 3 | 117 | 3 | 32574561 | |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 9452477 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 16549767 | ||
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 8471052 | ||
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 1.48e-07 | 4 | 117 | 3 | 8317488 | |
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 22406107 | ||
| Pubmed | 1.48e-07 | 4 | 117 | 3 | 8373352 | ||
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 1.48e-07 | 4 | 117 | 3 | 19151192 | |
| Pubmed | 7.37e-07 | 6 | 117 | 3 | 1530570 | ||
| Pubmed | 7.37e-07 | 6 | 117 | 3 | 17171436 | ||
| Pubmed | CCP110 CLIP2 FANCM SLC7A14 SLITRK1 FAN1 PPP1R26 HIVEP3 TRPM3 OSBPL3 MACF1 | 9.34e-07 | 493 | 117 | 11 | 15368895 | |
| Pubmed | 1.24e-06 | 101 | 117 | 6 | 10997877 | ||
| Pubmed | 1.29e-06 | 7 | 117 | 3 | 15276201 | ||
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 1.72e-06 | 26 | 117 | 4 | 14654843 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 2.05e-06 | 8 | 117 | 3 | 12634303 | |
| Pubmed | 3.12e-06 | 30 | 117 | 4 | 20200426 | ||
| Pubmed | ZCCHC8 ZNF518A PPP1R26 RLF SEC24D FBN2 CTR9 MACF1 RNF216 PLEC RNF111 | 5.31e-06 | 591 | 117 | 11 | 15231748 | |
| Pubmed | 6.09e-06 | 486 | 117 | 10 | 20936779 | ||
| Pubmed | TRAF3IP1 MYO5A CLIP2 DSP ZCCHC8 SMARCAD1 FRMD4B FAN1 FBN1 CTR9 MACF1 RNF216 TAF1 PLEC ZNF439 RNF111 | 6.63e-06 | 1285 | 117 | 16 | 35914814 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 7.37e-06 | 37 | 117 | 4 | 27565344 | |
| Pubmed | 7.40e-06 | 497 | 117 | 10 | 23414517 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12399449 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 21851253 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 2689439 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.12e-05 | 2 | 117 | 2 | 30044367 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 29789521 | ||
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.12e-05 | 2 | 117 | 2 | 21440062 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15131124 | ||
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 1.12e-05 | 2 | 117 | 2 | 2006920 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 3174634 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.12e-05 | 2 | 117 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.12e-05 | 2 | 117 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.12e-05 | 2 | 117 | 2 | 8307578 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24048194 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.12e-05 | 2 | 117 | 2 | 7744963 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8909248 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.12e-05 | 2 | 117 | 2 | 18006876 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 38804708 | ||
| Pubmed | DNA methylation is associated with altered gene expression in AMD. | 1.12e-05 | 2 | 117 | 2 | 22410570 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.12e-05 | 2 | 117 | 2 | 24833718 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12486119 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24399650 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22842574 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23675469 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27571988 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24265020 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20529844 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 34403156 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 38096518 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23133647 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 1.12e-05 | 2 | 117 | 2 | 1852206 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12429739 | ||
| Pubmed | Genomic organization and characterization of the promoter region of murine GSTM2 gene. | 1.12e-05 | 2 | 117 | 2 | 11404019 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 6500576 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.12e-05 | 2 | 117 | 2 | 12524050 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8120105 | ||
| Pubmed | Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. | 1.12e-05 | 2 | 117 | 2 | 12069689 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.12e-05 | 2 | 117 | 2 | 10504303 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 15062093 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10070062 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 1.12e-05 | 2 | 117 | 2 | 25524144 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 18692819 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12192076 | ||
| Pubmed | GSTM1 and GSTM5 Genetic Polymorphisms and Expression in Age-Related Macular Degeneration. | 1.12e-05 | 2 | 117 | 2 | 25897651 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 1.12e-05 | 2 | 117 | 2 | 16407178 | |
| Pubmed | Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. | 1.12e-05 | 2 | 117 | 2 | 24107997 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10359653 | ||
| Pubmed | 1.17e-05 | 225 | 117 | 7 | 12168954 | ||
| Pubmed | MYO5A CENPF DSP ZCCHC8 POLA1 ZC3H13 SRP68 SYNE2 MACF1 AATF PLEC | 1.35e-05 | 653 | 117 | 11 | 22586326 | |
| Pubmed | 1.41e-05 | 322 | 117 | 8 | 26514267 | ||
| Pubmed | 1.97e-05 | 163 | 117 | 6 | 24316575 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 10825173 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16842493 | ||
| Pubmed | Purification and characterization of glutathione S-transferase of murine ovary and testis. | 3.36e-05 | 3 | 117 | 2 | 8442656 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 8512323 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 30201140 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 8473333 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 29582627 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20855508 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 27995769 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 18062611 | ||
| Pubmed | Genetic susceptibility, residential radon, and lung cancer in a radon prone area. | 3.36e-05 | 3 | 117 | 2 | 24852519 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16822332 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12419833 | ||
| Pubmed | Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and eosinophils. | 3.36e-05 | 3 | 117 | 2 | 21046276 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 34818527 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16002077 | ||
| Pubmed | Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines. | 3.36e-05 | 3 | 117 | 2 | 27466493 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 19366731 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 3.36e-05 | 3 | 117 | 2 | 11592977 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 16244668 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20488846 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 3.36e-05 | 3 | 117 | 2 | 16407123 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 10587441 | ||
| Interaction | POTED interactions | 6.66e-07 | 4 | 112 | 3 | int:POTED | |
| Interaction | GSTM5 interactions | 1.18e-06 | 15 | 112 | 4 | int:GSTM5 | |
| Interaction | ANKRD20A4P interactions | 3.30e-06 | 6 | 112 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 5.75e-06 | 7 | 112 | 3 | int:ANKRD20A2P | |
| Interaction | GSTM2 interactions | 6.12e-06 | 22 | 112 | 4 | int:GSTM2 | |
| Interaction | NUP43 interactions | DSP POLA1 ZC3H13 SMARCAD1 ZNF518A HELB RLF FBN1 BBX SYNE2 ANKRD11 AATF SENP2 NKTR | 9.64e-06 | 625 | 112 | 14 | int:NUP43 |
| Interaction | USP7 interactions | POTEB3 CCP110 MYO5A DSP GIN1 ZCCHC8 POLA1 LRRK2 SRP68 CNKSR2 SMARCAD1 NEB ITGB3 POTEC ZNF594 FBN1 FBN2 MACF1 TAF1 PLEC WNK3 | 9.96e-06 | 1313 | 112 | 21 | int:USP7 |
| Interaction | DHX40 interactions | 1.06e-05 | 249 | 112 | 9 | int:DHX40 | |
| Interaction | ANKRD20A1 interactions | 2.67e-05 | 11 | 112 | 3 | int:ANKRD20A1 | |
| Interaction | CIAO1 interactions | 3.42e-05 | 289 | 112 | 9 | int:CIAO1 | |
| Interaction | POTEB3 interactions | 4.14e-05 | 35 | 112 | 4 | int:POTEB3 | |
| Interaction | POTEC interactions | 4.59e-05 | 13 | 112 | 3 | int:POTEC | |
| Interaction | GSTM1 interactions | 7.24e-05 | 15 | 112 | 3 | int:GSTM1 | |
| Interaction | GSTM4 interactions | 8.88e-05 | 16 | 112 | 3 | int:GSTM4 | |
| Interaction | PDZRN3 interactions | 1.23e-04 | 46 | 112 | 4 | int:PDZRN3 | |
| Cytoband | 1q41 | 2.56e-05 | 66 | 117 | 4 | 1q41 | |
| Cytoband | 1p13.3 | 3.05e-05 | 69 | 117 | 4 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 9.82e-05 | 93 | 117 | 4 | chr1q41 | |
| Cytoband | 15q21 | 3.49e-04 | 11 | 117 | 2 | 15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 2.14e-03 | 211 | 117 | 4 | chr1p13 | |
| Cytoband | 9p12 | 2.50e-03 | 29 | 117 | 2 | 9p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.64e-03 | 107 | 117 | 3 | chr11q22 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.43e-07 | 13 | 70 | 4 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | POTED ANKRD20A2P ANKRD20A3P POTEB2 POTEC ANKRD20A4P ANKRD11 POTEB ANKRD20A1 | 3.80e-07 | 242 | 70 | 9 | 403 |
| GeneFamily | Glutathione S-transferases | 2.45e-06 | 25 | 70 | 4 | 567 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.07e-06 | 8 | 70 | 3 | 939 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF366 ZSCAN26 ZNF440 ZNF518A ZNF710 RLF HIVEP3 ZNF594 ZNF700 ZNF439 | 4.21e-04 | 718 | 70 | 10 | 28 |
| GeneFamily | CD molecules|Integrin beta subunits | 5.23e-04 | 9 | 70 | 2 | 1159 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.94e-03 | 17 | 70 | 2 | 486 | |
| GeneFamily | Zinc fingers CCCH-type | 8.10e-03 | 35 | 70 | 2 | 73 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 3.19e-06 | 90 | 117 | 6 | M39250 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 6.98e-06 | 221 | 117 | 8 | M39222 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | MYO5A GIN1 ZC3H13 NEB FRMD4B SLITRK1 ZNF518A GSTM1 GSTM2 RLF BBX CCDC62 SYNE2 NKTR PLEC | 1.59e-05 | 770 | 114 | 15 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | MYO5A ZC3H13 FRMD4B PIK3IP1 GSTM1 GSTM2 RLF BBX CCDC62 RABGAP1L SYNE2 ANKRD11 NKTR ALDH2 PLEC | 2.31e-05 | 795 | 114 | 15 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CCP110 CENPF DSP GIN1 ZC3H8 POLA1 BTBD10 CNKSR2 ZNF518A CCDC62 RABGAP1L RNF216 AATF TAF1 WNK3 | 3.31e-05 | 820 | 114 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | ZNF366 ANKRD20A2P ANKRD20A3P FBN1 ANKRD20A4P ALDH2 ANKRD20A1 | 9.47e-07 | 198 | 117 | 7 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | ZNF366 ANKRD20A2P ANKRD20A3P FBN1 ANKRD20A4P ALDH2 ANKRD20A1 | 9.47e-07 | 198 | 117 | 7 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.76e-06 | 149 | 117 | 6 | 71d72a6e7b128ee96161e08f6a0d77be925e73a1 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.59e-06 | 156 | 117 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.69e-06 | 169 | 117 | 6 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.91e-06 | 179 | 117 | 6 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | 48d28eafbb5f4b141deeb0bf020dfca39e7be7a5 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 181 | 117 | 6 | 0a44781cc34535f061812d1370f748b7bbdef17b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.70e-06 | 182 | 117 | 6 | ad5c99ec62cdab347d3a03c971d981e3b924020c | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 9.84e-06 | 186 | 117 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 188 | 117 | 6 | 15d8dc514d5da46f6af284e7c1c92c606712dae6 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 1.05e-05 | 188 | 117 | 6 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 191 | 117 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.14e-05 | 191 | 117 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 191 | 117 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 1.18e-05 | 192 | 117 | 6 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 192 | 117 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 195 | 117 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-05 | 199 | 117 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.44e-05 | 199 | 117 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.07e-05 | 145 | 117 | 5 | b17699f7f98d2361a4d26c26f52db05e7ff69dff | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 4.34e-05 | 147 | 117 | 5 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.93e-05 | 151 | 117 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1-Excitatory_Neuron.Slc17a7.Parm1.Fos_(Deep_layer_pyramidal_cells--layer_5_(IEG))|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.08e-05 | 77 | 117 | 4 | 4879a1a72b950dadb78bc0312be75f1a32b935d5 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.90e-05 | 80 | 117 | 4 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.73e-05 | 166 | 117 | 5 | 479391aa6c09aa070b716128ab51b8fec0aea22d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 170 | 117 | 5 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.89e-05 | 171 | 117 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-04 | 176 | 117 | 5 | fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 176 | 117 | 5 | 5f8c1f917fba49f3b1c0d88b946eca242b668fde | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 177 | 117 | 5 | 1b077084b78e62ead603f72c9db6ce74a3953f81 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 177 | 117 | 5 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.05e-04 | 177 | 117 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.10e-04 | 179 | 117 | 5 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 180 | 117 | 5 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 180 | 117 | 5 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 180 | 117 | 5 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 182 | 117 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.25e-04 | 184 | 117 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.25e-04 | 184 | 117 | 5 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.29e-04 | 185 | 117 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 117 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.32e-04 | 186 | 117 | 5 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 117 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.39e-04 | 188 | 117 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.39e-04 | 188 | 117 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 191 | 117 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.53e-04 | 192 | 117 | 5 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|(1)_Control_(PBS) / Stress and Cell class | 1.53e-04 | 192 | 117 | 5 | 40f380f5f0bed63a7404be050838ebd01ef08987 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.53e-04 | 192 | 117 | 5 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.57e-04 | 193 | 117 | 5 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC2|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-04 | 194 | 117 | 5 | 833c695779edc94690b08814b0dedcf00ae082cd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 195 | 117 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.64e-04 | 195 | 117 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 195 | 117 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 1.68e-04 | 196 | 117 | 5 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.68e-04 | 196 | 117 | 5 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 196 | 117 | 5 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 196 | 117 | 5 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 196 | 117 | 5 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-04 | 196 | 117 | 5 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-04 | 196 | 117 | 5 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-04 | 197 | 117 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.72e-04 | 197 | 117 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-04 | 197 | 117 | 5 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.72e-04 | 197 | 117 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.76e-04 | 198 | 117 | 5 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class | 1.81e-04 | 199 | 117 | 5 | 90ddd686b8f39c6f6134b9b048396cebcf8d0448 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.81e-04 | 199 | 117 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 199 | 117 | 5 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 199 | 117 | 5 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| Computational | ROS metabolism. | 6.79e-06 | 22 | 62 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 2.13e-05 | 10 | 62 | 3 | MODULE_101 | |
| Computational | Genes in the cancer module 132. | 6.36e-05 | 14 | 62 | 3 | MODULE_132 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.75e-04 | 49 | 62 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | S-(formylmethyl)glutathione | 1.13e-07 | 24 | 114 | 5 | CID011954074 | |
| Drug | dimethoxystrychnine | 8.30e-07 | 35 | 114 | 5 | CID000009649 | |
| Drug | EUK-189 | 1.04e-06 | 16 | 114 | 4 | ctd:C436526 | |
| Drug | Clch2cosg | 1.73e-06 | 18 | 114 | 4 | CID000163913 | |
| Drug | C14791 | 1.73e-06 | 18 | 114 | 4 | CID011954044 | |
| Drug | C14793 | 1.73e-06 | 18 | 114 | 4 | CID011954046 | |
| Drug | C14803 | 1.73e-06 | 18 | 114 | 4 | CID011954054 | |
| Drug | C14805 | 1.73e-06 | 18 | 114 | 4 | CID011954056 | |
| Drug | C14804 | 1.73e-06 | 18 | 114 | 4 | CID011954055 | |
| Drug | C14806 | 1.73e-06 | 18 | 114 | 4 | CID011954057 | |
| Drug | C14848 | 1.73e-06 | 18 | 114 | 4 | CID011954067 | |
| Drug | C14856 | 1.73e-06 | 18 | 114 | 4 | CID011954069 | |
| Drug | C14855 | 1.73e-06 | 18 | 114 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 1.73e-06 | 18 | 114 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 1.73e-06 | 18 | 114 | 4 | CID000188517 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 2.42e-06 | 6 | 114 | 3 | ctd:C042630 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 2.71e-06 | 20 | 114 | 4 | CID011954072 | |
| Drug | C14865 | 2.71e-06 | 20 | 114 | 4 | CID011954073 | |
| Drug | C14802 | 3.74e-06 | 47 | 114 | 5 | CID011954053 | |
| Drug | C14800 | 4.15e-06 | 48 | 114 | 5 | CID011954051 | |
| Drug | bromobenzene-3,4-oxide | 4.61e-06 | 49 | 114 | 5 | CID000108121 | |
| Drug | bromobenzene-2,3-oxide | 5.10e-06 | 50 | 114 | 5 | CID003036760 | |
| Drug | 1,1-dichloroethylene epoxide | 5.10e-06 | 50 | 114 | 5 | CID000119521 | |
| Drug | naphthalene epoxide | 5.63e-06 | 51 | 114 | 5 | CID000108063 | |
| Drug | amodiaquine quinoneimine | 6.72e-06 | 8 | 114 | 3 | ctd:C094705 | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 7.11e-06 | 198 | 114 | 8 | 1588_UP | |
| Drug | dichloroacetaldehyde | 7.49e-06 | 54 | 114 | 5 | CID000006576 | |
| Drug | clotrimazole | 7.82e-06 | 143 | 114 | 7 | CID000002812 | |
| Drug | chloroacetyl chloride | 8.21e-06 | 55 | 114 | 5 | CID000006577 | |
| Drug | bromoacetaldehyde | 1.07e-05 | 58 | 114 | 5 | CID000105131 | |
| Drug | AC1Q608X | 1.11e-05 | 28 | 114 | 4 | CID000128466 | |
| Drug | AC1L33DC | 1.11e-05 | 28 | 114 | 4 | CID000133757 | |
| Drug | 2-BHA | 1.29e-05 | 29 | 114 | 4 | CID000006932 | |
| Drug | NSC39143 | 1.37e-05 | 61 | 114 | 5 | CID000002579 | |
| Drug | BP-4,5-oxide | 1.37e-05 | 61 | 114 | 5 | CID000037786 | |
| Drug | Dcvg | 1.69e-05 | 31 | 114 | 4 | CID006437359 | |
| Drug | o-dinitrobenzene | 1.69e-05 | 31 | 114 | 4 | CID000010707 | |
| Drug | m-toluidine | 2.46e-05 | 34 | 114 | 4 | CID000007934 | |
| Drug | Lyndiol | 2.46e-05 | 34 | 114 | 4 | CID000082149 | |
| Drug | Glutathione S-(2,4 Dinitrobenzene) | 2.49e-05 | 2 | 114 | 2 | DB02458 | |
| Drug | desethylamodiaquine | 2.60e-05 | 12 | 114 | 3 | ctd:C047386 | |
| Drug | clofibrate | 2.72e-05 | 311 | 114 | 9 | CID000002796 | |
| Drug | Dixan | 2.77e-05 | 35 | 114 | 4 | CID000010404 | |
| Drug | 1,2-dibromoethane | 2.88e-05 | 71 | 114 | 5 | CID000007839 | |
| Drug | Glutathione | 3.10e-05 | 36 | 114 | 4 | DB00143 | |
| Drug | CAS 87-33-2 | 3.30e-05 | 73 | 114 | 5 | CID000003780 | |
| Drug | stilbene oxide | 3.52e-05 | 74 | 114 | 5 | CID000028649 | |
| Drug | 2,4,6-trinitrotoluene | 3.76e-05 | 75 | 114 | 5 | CID000008376 | |
| Drug | Creosote | 3.86e-05 | 38 | 114 | 4 | ctd:D003407 | |
| Drug | BP-7,8-diol | 4.55e-05 | 78 | 114 | 5 | CID000025892 | |
| Drug | Ethoxyquin | 4.74e-05 | 40 | 114 | 4 | ctd:D005015 | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 2393_DN | |
| Drug | DAPM | 6.14e-05 | 135 | 114 | 6 | CID000007577 | |
| Drug | oltipraz | 6.66e-05 | 137 | 114 | 6 | CID000047318 | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A | 6.76e-05 | 200 | 114 | 7 | 4809_UP | |
| Drug | bis(agmatine)oxalamide | 7.43e-05 | 3 | 114 | 2 | CID003025845 | |
| Drug | Mfpa | 7.43e-05 | 3 | 114 | 2 | CID003035615 | |
| Drug | trichloroethylene | 8.11e-05 | 88 | 114 | 5 | CID000006575 | |
| Drug | 4-hydroxyanisole | 8.27e-05 | 46 | 114 | 4 | CID000009015 | |
| Drug | Fm 4-64 | 9.02e-05 | 90 | 114 | 5 | CID002733635 | |
| Drug | phenanthroline | 1.15e-04 | 50 | 114 | 4 | CID000067473 | |
| Drug | cumene hydroperoxide | 1.34e-04 | 52 | 114 | 4 | ctd:C007164 | |
| Drug | PCB 77 | 1.35e-04 | 98 | 114 | 5 | CID000036187 | |
| Drug | sulfolithocholic acid | 1.48e-04 | 4 | 114 | 2 | ctd:C014202 | |
| Drug | 4-chloronitrobenzene | 1.48e-04 | 4 | 114 | 2 | ctd:C010407 | |
| Drug | 3-methylcholanthrene | 1.66e-04 | 231 | 114 | 7 | CID000001674 | |
| Drug | S-hexylglutathione | 1.67e-04 | 55 | 114 | 4 | CID000005140 | |
| Drug | cyclohexanone | 1.92e-04 | 57 | 114 | 4 | CID000007967 | |
| Drug | tiadenol | 1.92e-04 | 57 | 114 | 4 | CID000023403 | |
| Drug | aminotriazole | 1.97e-04 | 167 | 114 | 6 | CID000001639 | |
| Drug | perhexiline | 2.05e-04 | 58 | 114 | 4 | CID000004746 | |
| Drug | piriprost | 2.34e-04 | 60 | 114 | 4 | CID006437373 | |
| Drug | AC1L1H6N | 2.46e-04 | 5 | 114 | 2 | CID000003999 | |
| Drug | 2-S-glutathionylcaffeic acid | 2.46e-04 | 5 | 114 | 2 | ctd:C082398 | |
| Drug | 3,4-dihydroxyphenylacetaldehyde | 2.46e-04 | 5 | 114 | 2 | ctd:C007430 | |
| Drug | PenCB | 2.50e-04 | 61 | 114 | 4 | CID000036188 | |
| Drug | diepoxybutane | 2.63e-04 | 113 | 114 | 5 | CID000011254 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 6.98e-10 | 5 | 103 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | mean platelet volume | MYO5A POLA1 LRRK2 ITGB3 ZNF710 GSTM1 GSTM2 BBX TRPM3 CTR9 CCDC62 SYNE2 TBC1D14 KCTD20 PCDHGB4 ANKRD11 PLEC | 8.84e-08 | 1020 | 103 | 17 | EFO_0004584 |
| Disease | Degenerative Diseases, Central Nervous System | 1.05e-05 | 39 | 103 | 4 | C0270715 | |
| Disease | Neurodegenerative Disorders | 1.05e-05 | 39 | 103 | 4 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 1.05e-05 | 39 | 103 | 4 | C0751733 | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 1.21e-05 | 2 | 103 | 2 | OBA_2041806 | |
| Disease | 3,7-dimethylurate measurement | 1.21e-05 | 2 | 103 | 2 | EFO_0800949 | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.61e-05 | 3 | 103 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Premature atrial contractions | 4.16e-05 | 55 | 103 | 4 | HP_0006699 | |
| Disease | scoliosis (is_implicated_in) | 7.21e-05 | 4 | 103 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | tea consumption measurement | 9.18e-05 | 129 | 103 | 5 | EFO_0010091 | |
| Disease | glutathione S-transferase Mu 1 measurement | 1.20e-04 | 5 | 103 | 2 | EFO_0801638 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | PR interval | 3.50e-04 | 495 | 103 | 8 | EFO_0004462 | |
| Disease | end stage renal disease (is_implicated_in) | 4.00e-04 | 41 | 103 | 3 | DOID:783 (is_implicated_in) | |
| Disease | immature platelet count | 5.29e-04 | 106 | 103 | 4 | EFO_0803544 | |
| Disease | immature platelet fraction | 6.96e-04 | 114 | 103 | 4 | EFO_0009187 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 7.78e-04 | 12 | 103 | 2 | C0403553 | |
| Disease | immature platelet measurement | 8.17e-04 | 119 | 103 | 4 | EFO_0803541 | |
| Disease | Heschl's gyrus morphology measurement | 8.52e-04 | 53 | 103 | 3 | EFO_0005852 | |
| Disease | Peripheral Nervous System Diseases | 9.00e-04 | 54 | 103 | 3 | C4721453 | |
| Disease | obesity (implicated_via_orthology) | 9.62e-04 | 215 | 103 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | refractive error | 1.01e-03 | 326 | 103 | 6 | MONDO_0004892 | |
| Disease | Autosomal recessive primary microcephaly | 1.23e-03 | 15 | 103 | 2 | cv:C3711387 | |
| Disease | ascending aortic diameter | 1.49e-03 | 140 | 103 | 4 | EFO_0021787 | |
| Disease | sphingomyelin 14:0 measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0010390 | |
| Disease | migraine disorder | 1.61e-03 | 357 | 103 | 6 | MONDO_0005277 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.83e-03 | 148 | 103 | 4 | C0279702 | |
| Disease | body surface area | 1.89e-03 | 643 | 103 | 8 | EFO_0022196 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.06e-03 | 153 | 103 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 2.20e-03 | 20 | 103 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | saturated fatty acids to total fatty acids percentage | 2.43e-03 | 21 | 103 | 2 | EFO_0022305 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.66e-03 | 22 | 103 | 2 | C3711387 | |
| Disease | systemic scleroderma (is_implicated_in) | 3.17e-03 | 24 | 103 | 2 | DOID:418 (is_implicated_in) | |
| Disease | neutrophil count | MYO1G ZNF366 RIOK3 GSTM1 MRPS18A GSTM2 HIVEP3 BBX RABGAP1L TBC1D14 ANKRD11 SCUBE3 | 3.18e-03 | 1382 | 103 | 12 | EFO_0004833 |
| Disease | osteonecrosis | 3.44e-03 | 25 | 103 | 2 | EFO_0004259 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSGDEAENCIHKKRE | 151 | A8MVM7 | |
| EHDRCTLKQENEEKT | 436 | Q5TYW2 | |
| EKEEKCHIEGIKEAI | 551 | Q8N715 | |
| EKEEGKSRHVDFQCV | 406 | Q9BSF8 | |
| AKPEEAHREELKECG | 966 | Q6UB99 | |
| QAKPEDSDCHRKIET | 591 | Q8WY36 | |
| KDKDIIEAVNHIADC | 166 | Q6P9F0 | |
| EHDRCTLKQENEEKT | 436 | Q4UJ75 | |
| QEEAHCLVEELRKTK | 146 | P10632 | |
| EVAKATSHICEVEKE | 381 | Q9UDT6 | |
| CDVEEHLKAKARAQE | 31 | Q9ULG3 | |
| VEECQCKVKTEHEDG | 236 | O95813 | |
| GTKQHQCDAELRKEI | 1811 | Q00975 | |
| EQRFCEHLKDEKGEE | 231 | Q9UBL0 | |
| DLEEAHREKSKGDCT | 421 | Q96SN8 | |
| PHKQTEDKGVQCEEE | 201 | Q9NQX3 | |
| NKDCDREVEEEIKKH | 371 | H3BUK9 | |
| DKDSRHNGEVTCKLE | 371 | Q9UN71 | |
| RQTEEEEGKDNHCFK | 1201 | Q8WYB5 | |
| EHDRCTLKQENEEKT | 436 | Q5SQ80 | |
| VHKNTEDRGDAEIKE | 161 | Q8TDR0 | |
| ARKHNLCGETEEEKI | 81 | P46439 | |
| EKEEGKSRHVDFQCV | 356 | Q7Z5Y7 | |
| EEKVKNHEDIFDCSR | 1211 | Q8IYD8 | |
| GEEEENQRKKAIAEH | 651 | Q2TBE0 | |
| ARKHNLCGESEKEQI | 81 | P28161 | |
| TKKEVHQARLECDEE | 936 | Q12986 | |
| TVCGKSVERQHKLEE | 2771 | O94854 | |
| GTHLDVSDEKQRKAC | 1451 | Q5S007 | |
| RGKDLKEQHDQKVCE | 196 | Q96FE7 | |
| AECALEKLTTDHEKD | 1401 | P09884 | |
| VEAKCKIQELEHQRG | 196 | B7ZAP0 | |
| EKREGKAEDRGQCNH | 416 | P26010 | |
| CDREVEEEIKKHGSN | 411 | A0JP26 | |
| KHTGKDPVRDECEER | 71 | Q8IZU1 | |
| DEDIVRDSGHIVKCL | 116 | Q9BRQ4 | |
| AKACVHKGQIEVESE | 161 | Q9Y2L6 | |
| EHDRCTLKQENEEKT | 436 | Q5VUR7 | |
| ENDKVIGADTKRNCH | 26 | Q9BXS1 | |
| CSVLKEELKQEDAHR | 391 | B1AJZ9 | |
| ENLEADSVCKIHEEK | 341 | P51878 | |
| EQKAREVCHLEAELK | 496 | P49454 | |
| SVRQLKEHAVEGDCD | 101 | P02765 | |
| GHKLNEVSQKCEDID | 276 | P35555 | |
| EEQKEKERGEAKHCF | 136 | Q14435 | |
| VHKGDECILKDNNER | 476 | P15924 | |
| AASEDQEKRDIAKGH | 386 | Q6PD62 | |
| LDKEHDAVEVADCVK | 261 | O43303 | |
| QVLHEETSGCKEEVK | 86 | A0A1B0GTR0 | |
| DKREDSQSDIKCHGT | 196 | Q9NY43 | |
| VECKKFDRGALHDEN | 641 | P05106 | |
| IHTGKAVDIDECKEI | 1801 | P35556 | |
| KHCKDVDECEREDNA | 66 | Q8IX30 | |
| RENSTLDVECHEKEK | 301 | Q6UVJ0 | |
| HIEQLEEREVKKACE | 491 | Q8NG08 | |
| SQTDIEREKLHGCID | 86 | Q9H4L5 | |
| HIDVTNCNKREKIEE | 291 | Q8N323 | |
| CDREVEEEIKKHGSN | 411 | B2RU33 | |
| CDREVEEEIKKHGSN | 411 | Q86YR6 | |
| EVVEKREACHCEEVK | 291 | Q9Y2M0 | |
| KEKLNSGVEVHLDCE | 411 | Q9P2F6 | |
| HCTVEEGVQKEEREK | 201 | Q9HC62 | |
| KETECNGERAKEEAI | 286 | Q9NQ86 | |
| EELEGELECHLVDKA | 1791 | O60522 | |
| DKQAEDRCHRVGQTK | 956 | Q9H4L7 | |
| GEDCIEAEEKVHVIE | 6736 | Q8WXH0 | |
| KVKSECHRVQEENAR | 1341 | Q5JRA6 | |
| NRGEEKSKSERECPH | 841 | P30414 | |
| LEGESVLDDECKKHL | 51 | Q8IZX4 | |
| QLEGESVLDDECKKH | 51 | P21675 | |
| NKDCDREVEEEIKKH | 371 | A0A0A6YYL3 | |
| ARKHNLCGETEEEKI | 81 | Q03013 | |
| SEEEKKKVLRECHEN | 66 | Q9NXP7 | |
| ARKHNLCGETEEEKI | 81 | P09488 | |
| KKNCSEEEHRIEAVE | 56 | A0A1B0GVY4 | |
| GLCQEEHRKIEECVK | 106 | Q9NVS2 | |
| EKRQHETQKCDGSVE | 236 | Q5T8A7 | |
| KEHNGLTCEELAEKD | 641 | Q9NWF9 | |
| EEHNELREVDGTAKK | 171 | Q13546 | |
| KAVKHAEELERLCES | 161 | Q9UHB9 | |
| IDCDKAVTVEFKHDD | 721 | O94855 | |
| CRKNDDGDTVVVVEK | 11 | P32856 | |
| GKENITEDEAKEVHR | 131 | Q5VW32 | |
| EEQECGDHRESKKSR | 126 | Q9NY61 | |
| EPKTDQDEEHCRKVN | 111 | Q16186 | |
| CQVAEGDKEDVDKAV | 66 | P05091 | |
| EGERKEAVATLEKEH | 756 | Q9UPV0 | |
| DRCKKIHAGDEVIQV | 251 | Q8WXI2 | |
| ENLAVKHKISREECD | 166 | P42765 | |
| DITTKHDEVVCGRKN | 161 | O14730 | |
| EEHTKKKEGILADCE | 446 | Q8TBB6 | |
| QQDCVHEAEEGSKLK | 216 | Q9P2M4 | |
| ICDDIHAKEKESNRR | 331 | A0JNW5 | |
| LIEEKVNEIKDDSHC | 66 | Q8IYI8 | |
| LIEEKVNEIKEDSHC | 86 | Q9H0M5 | |
| VLEEDHKVEESCAIK | 146 | Q6NZY4 | |
| HRVTQCDEENGTVKK | 146 | Q8N9B8 | |
| KKEENRSCESERTEH | 1611 | Q13129 | |
| QRKLHCKQDGEEGTE | 921 | Q6ZNA4 | |
| CNEIEGDLHVDCEKK | 31 | Q96PX8 | |
| DELKKVHDFEEQCIE | 1211 | Q9HCF6 | |
| HSKKCQETGVLEELE | 1806 | Q5T1R4 | |
| EEEVLEVEAACEKHT | 81 | Q8N1W2 | |
| EEKDERLHCENNDKA | 371 | Q6AHZ1 | |
| ERHGEKVEECQRFAK | 1396 | Q15149 | |
| EVHDRDRKSEECSQK | 56 | Q6ZUG5 | |
| SVKECEHAEKERQVS | 166 | A6NJ64 | |
| RHECEVTKPEKEKGE | 166 | Q16670 | |
| KSEHAPEVLEEACKE | 651 | Q8N895 | |
| HQRLHAGEKIEECEK | 341 | Q96JF6 | |
| EVDIHCSRAKEKEKQ | 1566 | O60346 | |
| EHEEQKVKPKNAEDC | 131 | Q9NZ63 | |
| AEGAIHEVKAACREE | 246 | Q702N8 | |
| SVKRCEAKLEGEHER | 1386 | Q5T200 | |
| VTEEKVNEIKEDSHC | 81 | Q8NDP4 | |
| IKGDQCKFDHDAEIE | 206 | Q8N5P1 | |
| SEHKDVVDGKISECA | 936 | Q9BYP7 | |
| EDKVAGKLDENHCRH | 606 | B0I1T2 | |
| QTRSEKKCIEEHADR | 1001 | Q9Y4I1 | |
| TICHVDEKAKDIEHA | 146 | P20929 |